oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Auroverin MR

It was found that the batch does not meet quality requirements due to a negative test result for the mebeverine hydrochloride release parameter, which may lead to improper release and reduced therapeutic efficacy. Potential effects: lack of efficacy, worsening of disease symptoms.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Auroverin MR
Risk Level
Medium
Manufacturer
Aurovitas Pharma Polska sp. z o.o. z siedzibą w Warszawie
Batch Number
EMBCD2064A
EAN Code
05909991340902
Recall Date
20.03.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use the specified batches of the medicine. Check the batch number on the package and, if you have the product, return it to the pharmacy. If in doubt or if symptoms occur, contact a doctor or p...

Actions Taken

The specified batches of the medicinal product were withdrawn from the market nationwide and a ban on placing them on the market was issued, with the decision given immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: It was found that the batch does not meet quality requirements due to a negative test result for the mebeverine hydrochloride release parameter, which may lead to improper release and reduced therapeutic efficacy. Potential effects: lack of efficacy, worsening of disease symptoms.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: EMBCD2064A

Related

Other Recalled Products